Related Experiment Video
Updated: May 20, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
Oncogenic B-Raf signaling in melanoma cells controls a network of microRNAs with combinatorial functions
K L Couts1, E M Anderson, M M Gross
1Department of Chemistry and Biochemistry, University of Colorado, Boulder, CO 80309-0215, USA.
Abstract:
Over two-thirds of melanomas have activating mutations in B-Raf, leading to constitutive activation of the B-Raf/MKK/ERK signaling pathway. The most prevalent mutation, B-RafV600E, promotes cancer cell behavior through mechanisms that are still incompletely defined. Here, we used a sensitive microarray profiling platform to compare microRNA (miRNA) expression levels between primary melanocytes and B-RafV600E-positive melanoma cell lines, and between melanoma cells treated in the presence and absence of an MKK1/2 inhibitor. We identified a network of >20 miRNAs deregulated by B-Raf/MKK/ERK in melanoma cells, the majority of which modulate the expression of key cancer regulatory genes and functions. Importantly, miRNAs within the network converge on protein regulation and cancer phenotypes, suggesting that these miRNAs might function combinatorially. We show that miRNAs augment effects on protein repression and cell invasion when co-expressed, and gene-specific latency and interference effects between miRNAs were also observed. Thus, B-Raf/MKK/ERK controls key aspects of cancer cell behavior and gene expression by modulating a network of miRNAs with cross-regulatory functions. The findings highlight the potential for complex interactions between coordinately regulated miRNAs within a network.
Insights
Activating mutations in B-Raf signaling drive melanoma. This study reveals a network of microRNAs (miRNAs) controlled by this pathway, impacting cancer cell behavior and gene regulation.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Activating mutations in B-Raf, particularly B-RafV600E, are prevalent in melanomas.
- These mutations lead to constitutive activation of the B-Raf/MKK/ERK signaling pathway, promoting cancer cell behavior.
- The precise mechanisms by which B-RafV600E influences melanoma progression are not fully understood.
Purpose of the Study:
- To investigate the role of microRNAs (miRNAs) in melanoma pathogenesis driven by B-Raf mutations.
- To identify miRNAs deregulated by the B-Raf/MKK/ERK pathway in melanoma cells.
- To explore the functional interactions and regulatory roles of these miRNAs in cancer phenotypes.
Main Methods:
- Utilized a microarray profiling platform to compare miRNA expression.
- Analyzed miRNA expression in primary melanocytes versus B-RafV600E-positive melanoma cell lines.
- Assessed the impact of an MKK1/2 inhibitor on miRNA expression in melanoma cells.
Main Results:
- Identified a network of over 20 miRNAs deregulated by the B-Raf/MKK/ERK pathway in melanoma.
- Found that these miRNAs modulate key cancer regulatory genes and functions, converging on protein regulation and cancer phenotypes.
- Demonstrated that co-expressed miRNAs can augment protein repression and cell invasion, with observed latency and interference effects.
Conclusions:
- The B-Raf/MKK/ERK pathway controls melanoma cell behavior and gene expression through the modulation of a miRNA network.
- These miRNAs exhibit cross-regulatory functions and may act combinatorially to influence cancer phenotypes.
- Highlights the potential for complex interactions within coordinately regulated miRNA networks in cancer.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades
The Ras Gene
Ras is a superfamily...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation

